TEXAS BIOMEDICAL RESEARCH INSTITUTE
SAN ANTONIO, Texas
Total Received
$270.4M
Total Awards
61
State
Texas
Last Updated
Mar 5, 2026
Yearly Funding Trend
$257.4M24
$12.3M25
$780K26
Top 50 Awards to TEXAS BIOMEDICAL RESEARCH INSTITUTE
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 5, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_P51OD011133_075 THE SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER - OVERALL ABSTRACT THE MISSION OF THE SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER (SNPRC) IS TO IMPROVE THE HEALTH OF OUR GLOBAL CO… | Department of Health and Human Services National Institutes of Health | 93.351 RESEARCH INFRASTRUCTURE PROGRAMS | SAN ANTONIO, TX-20 | 2024 | $122,234,337 |
ASST_NON_U42OD010442_075 ESTABLISHMENT OF A SPF RHESUS MACAQUE COLONY - ABSTRACT - OVERALL THE SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER (SNPRC) IS ONE OF SEVEN NATIONAL PRIMATE RESEARCH CENTERS (NPRCS)… | Department of Health and Human Services National Institutes of Health | 93.351 RESEARCH INFRASTRUCTURE PROGRAMS | SAN ANTONIO, TX-20 | 2024 | $32,637,736 |
ASST_NON_C06OD036038_075 FURTHER EXPANSION OF THE SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER SPECIFIC PATHOGEN FREE RHESUS MACAQUE RESOURCE - ABSTRACT THE SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER (SNPRC… | Department of Health and Human Services National Institutes of Health | 93.352 CONSTRUCTION SUPPORT | SAN ANTONIO, TX-20 | 2024 | $8,000,000 |
CONT_AWD_75A50123F61002_7505_75A50122D00020_7505 BIO-AMT-2303: GLP NATURAL HISTORY STUDIES IN NHP MODELS OF FILOVIRUS INFECTION | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN ANTONIO, TX-20 | 2024 | $6,694,756 |
ASST_NON_R01AI134245_075 MYELOID AND LYMPHOID IMMUNITY-SPECIFIC MECHANISMS OF IDO MEDIATED IMMUNOSUPPRESSION AND ITS REVERSAL, DURING TB - PROJECT SUMMARY WE HAVE DEVELOPED A MACAQUE MODEL OF MTB INFECTIO… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $6,248,028 |
ASST_NON_R01AI048071_075 MAPPING DRUG RESISTANCE GENES IN PLASMODIUM FALCIPARUM - ABSTRACT DRUG RESISTANCE MUTATIONS DISRUPT KEY PHYSIOLOGICAL PROCESSES RESULTING IN SEVERE FITNESS COSTS; COMPENSATORY MUT… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $5,443,843 |
ASST_NON_R01AI172539_075 DURABLE HIV VACCINE TARGETING MUCOSAL EPITHELIUM - ABSTRACT THE IMPRESSIVE AMOUNT OF DATA GENERATED BY EXPERIMENTAL HIV/SIV VACCINES HAS LED TO THE REALIZATION THAT PROTECTION WI… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $4,751,308 |
ASST_NON_P30AI168439_075 INTERDISCIPLINARY NEXGEN TB RESEARCH ADVANCEMENT CENTER (IN-TRAC) - TEXAS BIOMED IN-TRAC OVERALL ABSTRACT THE INTERDISCIPLINARY NEXGEN TB RESEARCH ADVANCEMENT CENTER (IN-TRAC) AT… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2024 | $4,649,066 |
ASST_NON_R01AI138587_075 SIGH BASED ATTENUATED, EFFICACIOUS MTB VACCINES TO PROTECT AGAINST LETHAL TB - ABSTRACT INFECTION WITH M. TUBERCULOSIS (MTB) CAN CAUSE TB, WHICH IS NOW THE LEADING GLOBAL CAUSE OF… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2024 | $4,359,340 |
ASST_NON_R01DA042524_075 ROLE OF MICRORNAS IN B-CELL DYSFUNCTION IN HIV/SIV INFECTION - DESCRIPTION (PROVIDED BY APPLICANT): B-CELL DYSFUNCTION IS A HALLMARK OF HIV/SIV INFECTION THAT BEGINS VERY EAR… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS | SAN ANTONIO, TX-20 | 2024 | $4,235,030 |
ASST_NON_R01AI134240_075 IMMUNE CORRELATES OF PROTECTION FROM TB - ABSTRACT. SINCE TB REMAINS AN INFECTION THAT RESULTS IN EXTENSIVE MORTALITY, EFFICACIOUS VACCINES AGAINST MTB INFECTION ARE URGENTLY SOUG… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2025 | $4,072,672 |
ASST_NON_R01DA052845_075 EPIGENETIC MECHANISMS UNDERLYING CANNABINOID MODULATION OF NEUROINFLAMMATION IN HIV/SIV INFECTION - ABSTRACT HIV ASSOCIATED NEUROLOGICAL DISORDER (HAND), A MAJOR COMORBIDITY AFFEC… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | TX-90 | 2024 | $3,997,990 |
ASST_NON_R01AI170197_075 UNDERSTANDING CO-MORBIDITIES: COVID-19 IN INDIVIDUALS LIVING WITH HIV/AIDS - SUMMARY WHILE COVID-19 CONTINUES TO BE A HEALTH CHALLENGE, VERY LITTLE IS KNOWN ABOUT HOW COVID-19 AFF… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2024 | $3,900,756 |
ASST_NON_R01AI136831_075 MACROPHAGE NUCLEAR RECEPTORS, METABOLISM AND IMMUNE EFFECTORS DURING HEALTH AND M. TUBERCULOSIS INFECTION - PROJECT SUMMARY/ABSTRACT HUMAN LUNGS, WHILE MEDIATING AIR EXCHANGE IN T… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2024 | $3,797,762 |
ASST_NON_R01AG065546_075 MICROBIOME-MEDIATED THERAPIES FOR AGING AND HEALTHSPAN IN MARMOSETS - PROJECT SUMMARY THE NUMBER ONE COMPLAINT GIVEN BY THE ELDERLY IS NOT PAIN AND DISCOMFORT, BUT RATHER THE NEED… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | TX-90 | 2024 | $3,381,296 |
ASST_NON_R01MH116844_075 CNS MYELOID CELLS AS SIV RESERVOIRS: PERSISTENT INFECTION AND REBOUND - PROJECT SUMMARY (ABSTRACT) PREVENTING REBOUND OF HIV FOLLOWING ANTIRETROVIRAL THERAPY INTERRUPTION (ATI) RE… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | SAN ANTONIO, TX-20 | 2024 | $3,361,337 |
ASST_NON_R01MH130193_075 BRAIN MYELOID CELL-TARGETED MULTIPLEXED GENE EDITING FOR SIV/HIV ERADICATION - PROJECT SUMMARY THE LONG-LIVED MYELOID CELLS SUCH AS PERIVASCULAR MACROPHAGES AND MICROGLIA IN THE… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | SAN ANTONIO, TX-20 | 2024 | $3,268,167 |
ASST_NON_R01AI166049_075 GENOMIC CONSEQUENCES OF SCHISTOSOME HYBRIDIZATION - HYBRIDIZATION BETWEEN PARASITE SPECIES HAS THE POTENTIAL TO TRANSFER BIOMEDICALLY IMPORTANT GENES ACROSS SPECIES BOUNDARIES WIT… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $3,122,895 |
ASST_NON_R01AI176309_075 IMPROVING RAPID PHENOTYPIC DRUG SUSCEPTIBILITY TESTING FOR DRUG RESISTANT TUBERCULOSIS IN HIGH-BURDEN AREAS - ABSTRACT TUBERCULOSIS (TB), CAUSED BY MYCOBACTERIUM TUBERCULOSIS (M.T… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $2,692,722 |
ASST_NON_R01AI133749_075 GENETIC ANALYSIS OF CERCARIAL RELEASE IN SCHISTOSOMES - SUMMARY IDENTIFICATION OF THE PARASITE GENES THAT INFLUENCE TRANSMISSION, VIRULENCE AND HOST SPECIFICITY IS OF CENTRAL INTE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $2,545,442 |
ASST_NON_ED24AUS0G0097_013 THIS EDA INVESTMENT WILL LEVERAGE RECOVERY AND RESILIENCE IN SAN ANTONIO, TEXAS. TEXAS BIOMEDICAL RESEARCH INSTITUTE IS ADDRESSING THE LOCAL AND REGIONAL NEED FOR HIGH-VALUE LIFE… | Department of Commerce Economic Development Administration | 11.307 ECONOMIC ADJUSTMENT ASSISTANCE | SAN ANTONIO, TX-20 | 2024 | $2,500,000 |
ASST_NON_R01AI158963_075 MATHEMATICAL MODELING OF MYCOBACTERIUM TUBERCULOSIS DISSEMINATION - RESEARCH SUMMARY TUBERCULOSIS (TB), A DISEASE CAUSED BY THE BACTERIA MYCOBACTERIUM TUBERCULOSIS (MTB), REMAINS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $2,474,639 |
ASST_NON_R01AI184623_075 MECHANISMS OF EFFICIENT CONTROL OF MYCOBACTERIUM TUBERCULOSIS IN THE LUNGS PRIOR TO GRANULOMA - PROJECT SUMMARY/ABSTRACT. NOVEL VACCINATION STRATEGIES ARE NECESSARY TO CONTAIN THE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $2,322,288 |
ASST_NON_R01AI184581_075 IMPACT OF HIV ON THE HUMAN ALVEOLAR ENVIRONMENT DRIVINGTHE EARLY EVENTS OF MYCOBACTERIUM TUBERCULOSIS INFECTION - ABSTRACT TUBERCULOSIS (TB), CAUSED BY MYCOBACTERIUM TUBERCULOSIS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $1,973,493 |
ASST_NON_R01AI157850_075 ROLE OF CELLULAR LONG NON-CODING RNAS IN HIV REPLICATION AND DISEASE OUTCOME - SUMMARY THE MAJORITY OF THE HUMAN TRANSCRIPTOME CONSISTS OF LONG NON-CODING RNAS (LNCRNAS), WHICH RE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $1,970,200 |
ASST_NON_R01AI179412_075 INTRARECTAL IMMUNIZATION FOR A BARRIER TO MUCOSAL HIV INFECTION - ABSTRACT THE IMPRESSIVE AMOUNT OF DATA GENERATED BY EXPERIMENTAL BUT MOSTLY UNSUCCESSFUL HIV/SIV VACCINES HAS LE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $1,888,173 |
ASST_NON_R01DA064139_075 USE OF FOCUSED ULTRASOUND STIMULATED BLOOD BRAIN BARRIER OPENING FOR CNS HIV/SIV RESERVOIR REDUCTION - ABSTRACT THE ADVENT OF COMBINATION ANTI-RETROVIRAL THERAPY (CART) HAS PROLON… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | TX-90 | 2025 | $1,825,990 |
ASST_NON_R01AI181701_075 MODULATING INDOLEAMINES TO OPTIMIZE IMMUNITY IN THE SETTING OF MTB/HIV CO-INFECTION - PROJECT SUMMARY TB REMAINS THE LEADING CAUSE OF DEATH IN HIV-INFECTED PERSONS, WITH ONE IN FO… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $1,820,801 |
ASST_NON_R01AI179465_075 VIRAL AND HOST DETERMINANTS OF DONOR-SPECIFIC ANTI-HIV/SIV IMMUNITY MEDIATED BY APOBEC3-ENZYME - PROJECT SUMMARY HUMAN APOBEC3 ENZYMES, PARTICULARLY APOBEC3D, APOBEC3F, APOBEC3G,… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $1,679,173 |
ASST_NON_R61AI169026_075 ADVANCING INNOVATIVE NEXT_GENERATION HETEROLOGOUS VACCINES AGAINST TUBERCULOSIS - PROJECT SUMMARY/ABSTRACT THROUGHOUT MODERN HISTORY, TUBERCULOSIS (TB) HAS KILLED MORE PEOPLE THAN… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $1,615,572 |
ASST_NON_W81XWH1910496_097 DEVELOPMENT OF LIVE-ATTENUATED VIRUS VACCINE PLATFORM AGAINST HEMORRHAGIC FEVER CAUSING ARENAVIRUSES EXTEND THE PERIOD OF PERFORMANCE | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2024 | $1,465,710 |
ASST_NON_U34AG068482_075 CHARACTERIZATION OF MARMOSETS AS A GEROSCIENCE MODEL BY THE SAN ANTONIO MAP - IN RESPONSE TO RFA-AG-20-007, WE ADDRESS THE FOA TO “FACILITATE THE CHARACTERIZATION OF THE MARMOSET… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | TX-90 | 2024 | $1,362,452 |
ASST_NON_R01DA064212_075 TARGETED CRISPR/CAS EDITING TO ELIMINATE SIV CNS RESERVOIR IN METHAMPHETAMINE-EXPOSED RHESUS MACAQUES ON ART - SUMMARY IN THE ONGOING BATTLE AGAINST HIV, CURRENT ANTIRETROVIRAL TH… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | TX-90 | 2025 | $1,144,344 |
ASST_NON_R25GM142021_075 IT'S CONTAGIOUS! PROMOTING THE BIOMEDICAL WORKFORCE PIPELINE THROUGH INFECTIOUS DISEASES - ENTER THE TEXT HERE THAT IS THE NEW ABSTRACT INFORMATION FOR YOUR APPLICATION. THIS SEC… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | SAN ANTONIO, TX-20 | 2024 | $1,039,931 |
ASST_NON_W81XWH1920020_097 ZIKA VIRUS COUNTERMEASURES: PRECLINICAL PREGNANCY MODELS TO ASSESS PROTECTIVE EFFICACY AGAINST PLACENTAL DAMAGE AND FETAL DEMISE DE-OBLIGATE FUNDS TO CLOSE AWARD 1. PER SECTION 71… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN ANTONIO, TX-20 | 2024 | $989,482 |
ASST_NON_R01AI189313_075 EVALUATING THE SAFETY, IMMUNOGENICITY AND EFFICACY OF A ROBUST ATTENUATED MTB VACCINE IN THE SETTING OF HIV CO-INFECTION - PROJECT SUMMARY/ABSTRACT. NOVEL VACCINATION STRATEGIES A… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2025 | $905,998 |
ASST_NON_R56AI174877_075 DONOR-SPECIFIC ANTI-HIV/SIV IMMUNITY MEDIATED BY APOBEC3 ENZYMES - PROJECT SUMMARY HUMAN APOBEC3 ENZYMES, PARTICULARLY APOBEC3D, APOBEC3F, APOBEC3G, AND STABLE HAPLOTYPES OF APOBE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2025 | $827,119 |
ASST_NON_R21AI170148_075 SINGLE CELL TRANCRIPTOMICS TO IDENTIFY LTBI REACTIVATION MARKERS IN TB/HIV CO-INFECTION - PROJECT SUMMARY THE GLOBAL CONTROL OF TUBERCULOSIS (TB) IS COMPOUNDED BY CO-INFECTION WIT… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2025 | $799,839 |
ASST_NON_R21AI165289_075 PIGTAIL MACAQUE MODEL OF HUMAN-SIMIAN IMMUNODEFICIENCY VIRUS INFECTION - ABSTRACT/SUMMARY: COMMONLY USED ANIMAL MODELS OF HIV-1 INCLUDE INFECTION OF MACAQUES WITH SIMIAN IMMUNODEF… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2025 | $756,000 |
ASST_NON_R56AI184089_075 EFFECT OF IL-21 TREATMENT CONCURRENT TO ART AND 3HP IN MTB/SIV CO-INFECTION - ABSTRACT THE GLOBAL CONTROL OF TB IS COMPOUNDED BY CO-INFECTION WITH HIV. THOSE INFECTED WITH HIV ARE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2024 | $718,758 |
ASST_NON_K01OD026529_075 PATHOGENESIS OF AND HOST RESPONSE TO CHIKUNGUNYA VIRUS INFECTION OF THE CENTRAL NERVOUS SYSTEM - ABSTRACT THE PURPOSE OF THIS K01 SERCA APPLICATION IS TO PROVIDE THE PROTECTED RES… | Department of Health and Human Services National Institutes of Health | 93.351 RESEARCH INFRASTRUCTURE PROGRAMS | TX-90 | 2025 | $630,169 |
ASST_NON_K01OD031898_075 CHARACTERIZING IL-22 DRIVEN CHRONIC IMMUNE ACTIVATION IN HIV/TB CO-PANDEMIC - PROJECT SUMMARY THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND TUBERCULOSIS (TB) CO-PANDEMIC POSES A MAJO… | Department of Health and Human Services National Institutes of Health | 93.351 RESEARCH INFRASTRUCTURE PROGRAMS | TX-90 | 2025 | $566,664 |
ASST_NON_R21AI168934_075 NOVEL ANTIVIRAL STRATEGY OFFERING FORWARD CAPABILITY AND REDUCED RISK OF ESCAPE - ABSTRACT THE CURRENT CORONAVIRUS (COV) PANDEMIC, SEASONAL INFECTIONS BY OTHER COV AND OTHER “COL… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2024 | $544,500 |
ASST_NON_R21AI154336_075 TUNNELING NANOTUBES AS AN ALTERNATE ROUTE OF EBOLA VIRUS DISSEMINATION - EBOLA VIRUS (EBOV) IS AN EMERGING, DANGEROUS VIRUS THAT CAUSES INCREASINGLY MORE FREQUENT OUTBREAKS OF A S… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $544,500 |
ASST_NON_R21AI151717_075 THE ROLE OF MACROPHAGE PODOSOMES IN EBOLA VIRUS PATHOGENESIS - PROJECT SUMMARY EBOLA VIRUS (EBOV) IS AN EMERGING, HIGHLY PATHOGENIC VIRUS ASSOCIATED WITH INCREASINGLY MORE FREQUEN… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $544,500 |
ASST_NON_R21AI171601_075 ROLE OF THE MICROBIOME OF THE SCHISTOSOME SNAIL HOST - PROJECT SUMMARY THE MICROBIOME – THE COMMUNITY OF MICROORGANISMS THAT INHABIT BOTH THE HUMAN BODY AND THAT OF MULTIPLE OTHER… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2025 | $544,500 |
ASST_NON_R21NS135258_075 MODELING CHIKUNGUNYA VIRUS NEUROINVASION AND NEUROPATHOGENESIS IN MICE - PROJECT SUMMARY THE ALPHAVIRUS CHIKUNGUNYA VIRUS (CHIKV) REPRESENTS A RE-EMERGING PUBLIC HEALTH CONCERN AS… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | TX-90 | 2026 | $544,500 |
ASST_NON_R21AI152200_075 ENGINEERING PATHOGEN TRIGGERED BIOMINERALIZATION TO ENABLE A NEW GENERATION OF POINT-OF-CARE TESTS - ABSTRACT BIOMINERALIZATION IS A COALESCENCE OF ORGANIC (SOFT) AND INORGANIC (H… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | TX-90 | 2024 | $544,308 |
ASST_NON_R21AI156467_075 NANOBODY TOOLKIT FOR HUMAN CORONAVIRUS CLASSIFICATION - ABSTRACT THE ENDEMIC HUMAN CORONAVIRUSES (HCOV) NL63, OC43, 229E AND HKU1 HAVE TYPICALLY BEEN ASSOCIATED WITH RELATIVELY M… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $539,990 |
ASST_NON_R21AI150445_075 DETERMINING THE EFFICACY OF A NOVEL TB DIAGNOSTIC TEST TO MONITOR TREATMENT SUCCESS IN DRUG RESISTANT TB PATIENTS - ABSTRACT TUBERCULOSIS (TB) IS NOW THE LEADING INFECTIOUS DISEAS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN ANTONIO, TX-20 | 2024 | $421,828 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.351 — RESEARCH INFRASTRUCTURE PROGRAMS$156.2M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$69.4M
93.279 — DRUG USE AND ADDICTION RESEARCH PROGRAMS$11.2M
93.352 — CONSTRUCTION SUPPORT$8.0M
93.242 — MENTAL HEALTH RESEARCH GRANTS$6.6M
93.866 — AGING RESEARCH$5.1M
11.307 — ECONOMIC ADJUSTMENT ASSISTANCE$2.5M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$2.5M
93.859 — BIOMEDICAL RESEARCH AND RESEARCH TRAINING$1.0M
93.853 — EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$545K
Source: USAspending.gov · All Recipients · Texas